Immune response to Leishmania infection in human skin

Clinics in Dermatology

Volumn 17, Issue 3, 1999, Pages 333-338

  Ghersetich, Ilaria ^a   Menchini, Giovanni ^a   Teofoli, Patrizia ^a   Lotti, Torello ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ARTICLE; CELLULAR IMMUNITY; CYTOKINE RELEASE; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LEISHMANIA; LEISHMANIASIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032702715     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00053-X     Document Type: Review

References (39)

1. Rosen T. Leishmaniasis and the JEADV. Editorial. J Eur Acad Dermatol Venereol. 10:1998;212-213.
2. Lainson R., Shaw J.J. Evolution, classification and geographical distribution. Peters W., Killick-Kendrick R. The Leishmaniases in biology and medicine, Vol. 1. 1987;1-120 Academic Press, London.
3. Pratt D.M., David J.R. Monoclonal antibodies that distinguish between New World species of Leishmania. Nature. 291:1981;581-583.
4. Ridley D.S. A histological classification of cutaneous leishmaniasis and its geographical expression. Trans R Soc Trop Med Hyg. 74:1980;515-521.
5. Haldar J.P., Ghose S., Saha K.C. Cell mediated immune response in Indian Kala azar and post-kala azar dermal Leishmaniasis. Inf Immunol. 42:1983;702-707.
6. Sen Gupta P.C., Battachatjee B. Histopathology of post-kala azar dermal Leishmaniasis. J Trop Med Hyg. 56:1953;110-116.
7. Pampiglione S., Mansor-Bahr P.E.C., La Placa M. Studies on Mediterranean Leishmaniasis. 3. The Leishmanin test in Kala-azar. Trans R Soc Trop Med Hyg. 69:1975;60-68.
8. Dowlati Y. Cutaneous Leishmaniasis. Int J Dermatol. 18:1979;362-368.
9. Kotwal G.J. Microorganisms and their interaction with the immune system. J Leukocyte Biology. 62:1997;415-429.
10. Kotwal GJ, McKenzie R, Isaacs SN, et al. Viral encoded molecules for evasion of host defence mechanisms. In: Marchalonis JJ, Reonish CL, editors). Defence Molecules. New York: Wiley-Liss, 149-60.
11. Bogdan C., Rollinghoff M. The immune response to Leishmania Mechanisms of parasite control and evasion . Int J Parasitol. 28:1998;121-134.
12. Scharton-Kersten T., Scott P. The role of the innate immune response in Th1 cell development following Leishmania major infection. J Leukocyte Biology. 57:1995;515-520.
13. Kemp M., Theander T.G., Kharazmi A. The contrasting roles of CD4+ T cell in intracellular infections in humans Leishmaniasis as an example . Immunol Today. 17:1996;13-16.
14. Coffman R.L., Seymour B.W.P., Lebman D.A., et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev. 102:1988;5-28.
15. Scott P., Kaufmann S. The role of T-cell subsets cytokines in the regulation of infection. Immunol Today. 12:1991;346-348.
16. Janeway C.A. The immune system evolved to criminate infectious nonself from noninfectious self. Immunol Today. 13:1994;11-16.
17. Herberman R.B., Ortaldo J.R. Natural killer cells Role in defenses against disease . Science. 214:1981;24-30.
18. Trinchieri G. Biology of natural killer cells. Immunol Today. 47:1989;187-386.
19. Romagnani S. Induction of Th1 and Th2 response key role for the "natural" immune response? Immunol Today. 13:1992;379-383.
20. Coffman R.L., Varkila K., Scott P., et al. The roles of cytokines in differentiation of CD4+ T-cell subsets in vitro. Immunol Rev. 123:1991;189-207.
21. Romagnani S. Regulatory role of IL-4 and other cytokines in the function and development of human T-cell clones. Res Immunol. 144:1993;625-629.
22. Sadik M.D., Loksley R.M., Tubbs C., et al. Murine cutaneous leishmaniasis Resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro . J Immunol. 136:1986;655-661.
23. Vivira L.Q., Hondowicz B., Alfonso L.C., et al. Infection with Leishmania major induces interleukin-12 production in vivo. Immunol Lett. 40:1994;157-161.
24. Nacy C.A., Meltzer M.S., Leonard E.J., Wyler D.J. Intracellular replication and lymphokine induced destruction of Leishmania tropica in C3H/HcN mouse macrophages. J Immunol. 127:1981;238-247.
25. Murphy E.E., Terres G., Macatonia S.E., et al. B7 and Interleukin 12 cooperate for proliferation and interferon-gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med. 178:1994;1041.
26. Schmitt E., Hoen P., Huels C., et al. T helper type 1 development of natural CD4+ T cells requires the coordinate action of interleukine and interferon-gamma and is inhibited by transforming growth factor-beta. Eur J Immunol. 24:1994;793-798.
27. Seder R.A., Paul W.E. Acquisition of limphokine producing phenotype by CD4+ T cells. Annu Rev Immunol. 12:1994;635-673.
28. Huang F.P., Xu D., Esfandiari E.O., et al. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production. J Immunol. 160:1998;4143-4147.
29. Stalder T., Hahn S., Erb P. Fas antigen is the major target molecule for CD4+ T-cell mediated cytotoxicity. J Immunol. 152:1994;1127.
30. Kaye P.M. Costimulation and the regulation of antimicrobial immunity. Immunol Today. 16:1995;423-427.
31. June C.H., Bluestone J.A., Nadler L.M., Thompson C.B. The B7 and CD28 receptor families. Immunol Today. 15:1994;321-331.
32. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science. 248:1990;1349-1356.
33. Lenschow D.J., Bluestone J.A. T cell co-stimulation and in vivo tolerance. Curr Opin Immunol. 5:1993;747-752.
34. Kaye P.M., Rogers N.J., Curry A.J., Scott J.C. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. Eur J Immunol. 24:1994;2850-2854.
35. Reiner N.E. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol Today. 15:1994;374-381.
36. Miralles G.D., Stoeckle M.Y., McDermott D.F., et al. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun. 62:1994;1058-1062.
37. Descoteaux A., Turco S.J., Stacks D.L., Matlashewski G. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. J Immunol. 146:1991;2747-2753.
38. Moll H. Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis. Immunol Today. 14:1993;383-387.
39. Alfonso L.C.C., Scharton T.M., Vieira L.Q., et al. The adjuvant effect of interleukine 12 in a vaccine against Leishmania major. Science. 2:1994;235-237.